Cost-Effectiveness Analysis of The Paliperidone Palmitate 3-Month Formulation Versus 1-Month Formulation From A Healthcare Payer Perspective
OBJECTIVES: Schizophrenic episodes cause socio-economic problems and compliance with therapy is a known problem for schizophrenia patients and their families.The 3-monthly paliperidone palmitate formulation(PP3M) offers long-term benefits for patients by preventing schizophrenic episodes,also reduci...
Gespeichert in:
Veröffentlicht in: | Value in health 2017-10, Vol.20 (9), p.A713 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!